Global In Vivo Imaging Solutions Market 2025 by Company, Regions, Type and Application, Forecast to 2031

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of In Vivo Imaging Solutions by Type
  • 1.3.1 Overview: Global In Vivo Imaging Solutions Market Size by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Global In Vivo Imaging Solutions Consumption Value Market Share by Type in 2024
  • 1.3.3 In Vivo Imaging Instruments
  • 1.3.4 In Vivo Imaging Reagents
  • 1.3.5 In Vivo Imaging Software
  • 1.3.6 In Vivo Imaging Accessories
• 1.4 Global In Vivo Imaging Solutions Market by Application
  • 1.4.1 Overview: Global In Vivo Imaging Solutions Market Size by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Laboratories
  • 1.4.3 Vet Hospitals and Clinics
• 1.5 Global In Vivo Imaging Solutions Market Size & Forecast
• 1.6 Global In Vivo Imaging Solutions Market Size and Forecast by Region
  • 1.6.1 Global In Vivo Imaging Solutions Market Size by Region: 2020 VS 2024 VS 2031
  • 1.6.2 Global In Vivo Imaging Solutions Market Size by Region, (2020-2031)
  • 1.6.3 North America In Vivo Imaging Solutions Market Size and Prospect (2020-2031)
  • 1.6.4 Europe In Vivo Imaging Solutions Market Size and Prospect (2020-2031)
  • 1.6.5 Asia-Pacific In Vivo Imaging Solutions Market Size and Prospect (2020-2031)
  • 1.6.6 South America In Vivo Imaging Solutions Market Size and Prospect (2020-2031)
  • 1.6.7 Middle East & Africa In Vivo Imaging Solutions Market Size and Prospect (2020-2031)

2 Company Profiles

• 2.1 Revvity
  • 2.1.1 Revvity Details
  • 2.1.2 Revvity Major Business
  • 2.1.3 Revvity In Vivo Imaging Solutions Product and Solutions
  • 2.1.4 Revvity In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Revvity Recent Developments and Future Plans
• 2.2 Berthold Technologies
  • 2.2.1 Berthold Technologies Details
  • 2.2.2 Berthold Technologies Major Business
  • 2.2.3 Berthold Technologies In Vivo Imaging Solutions Product and Solutions
  • 2.2.4 Berthold Technologies In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Berthold Technologies Recent Developments and Future Plans
• 2.3 Analytik Jena
  • 2.3.1 Analytik Jena Details
  • 2.3.2 Analytik Jena Major Business
  • 2.3.3 Analytik Jena In Vivo Imaging Solutions Product and Solutions
  • 2.3.4 Analytik Jena In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Analytik Jena Recent Developments and Future Plans
• 2.4 Azure Biosystems
  • 2.4.1 Azure Biosystems Details
  • 2.4.2 Azure Biosystems Major Business
  • 2.4.3 Azure Biosystems In Vivo Imaging Solutions Product and Solutions
  • 2.4.4 Azure Biosystems In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Azure Biosystems Recent Developments and Future Plans
• 2.5 LICORBio
  • 2.5.1 LICORBio Details
  • 2.5.2 LICORBio Major Business
  • 2.5.3 LICORBio In Vivo Imaging Solutions Product and Solutions
  • 2.5.4 LICORBio In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 LICORBio Recent Developments and Future Plans
• 2.6 Scintica Instrumentation
  • 2.6.1 Scintica Instrumentation Details
  • 2.6.2 Scintica Instrumentation Major Business
  • 2.6.3 Scintica Instrumentation In Vivo Imaging Solutions Product and Solutions
  • 2.6.4 Scintica Instrumentation In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 Scintica Instrumentation Recent Developments and Future Plans
• 2.7 Vieworks
  • 2.7.1 Vieworks Details
  • 2.7.2 Vieworks Major Business
  • 2.7.3 Vieworks In Vivo Imaging Solutions Product and Solutions
  • 2.7.4 Vieworks In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Vieworks Recent Developments and Future Plans
• 2.8 Thermo Fisher Scientific
  • 2.8.1 Thermo Fisher Scientific Details
  • 2.8.2 Thermo Fisher Scientific Major Business
  • 2.8.3 Thermo Fisher Scientific In Vivo Imaging Solutions Product and Solutions
  • 2.8.4 Thermo Fisher Scientific In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 Thermo Fisher Scientific Recent Developments and Future Plans
• 2.9 Ningbo Icoe Commodity
  • 2.9.1 Ningbo Icoe Commodity Details
  • 2.9.2 Ningbo Icoe Commodity Major Business
  • 2.9.3 Ningbo Icoe Commodity In Vivo Imaging Solutions Product and Solutions
  • 2.9.4 Ningbo Icoe Commodity In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 Ningbo Icoe Commodity Recent Developments and Future Plans
• 2.10 Canon Medical Systems
  • 2.10.1 Canon Medical Systems Details
  • 2.10.2 Canon Medical Systems Major Business
  • 2.10.3 Canon Medical Systems In Vivo Imaging Solutions Product and Solutions
  • 2.10.4 Canon Medical Systems In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.10.5 Canon Medical Systems Recent Developments and Future Plans
• 2.11 Bruker
  • 2.11.1 Bruker Details
  • 2.11.2 Bruker Major Business
  • 2.11.3 Bruker In Vivo Imaging Solutions Product and Solutions
  • 2.11.4 Bruker In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.11.5 Bruker Recent Developments and Future Plans
• 2.12 Hallmarq Veterinary Imaging
  • 2.12.1 Hallmarq Veterinary Imaging Details
  • 2.12.2 Hallmarq Veterinary Imaging Major Business
  • 2.12.3 Hallmarq Veterinary Imaging In Vivo Imaging Solutions Product and Solutions
  • 2.12.4 Hallmarq Veterinary Imaging In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.12.5 Hallmarq Veterinary Imaging Recent Developments and Future Plans
• 2.13 Huan Tong Nuclear Magnetic
  • 2.13.1 Huan Tong Nuclear Magnetic Details
  • 2.13.2 Huan Tong Nuclear Magnetic Major Business
  • 2.13.3 Huan Tong Nuclear Magnetic In Vivo Imaging Solutions Product and Solutions
  • 2.13.4 Huan Tong Nuclear Magnetic In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.13.5 Huan Tong Nuclear Magnetic Recent Developments and Future Plans
• 2.14 Sunny Optical Technology
  • 2.14.1 Sunny Optical Technology Details
  • 2.14.2 Sunny Optical Technology Major Business
  • 2.14.3 Sunny Optical Technology In Vivo Imaging Solutions Product and Solutions
  • 2.14.4 Sunny Optical Technology In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.14.5 Sunny Optical Technology Recent Developments and Future Plans
• 2.15 Photon
  • 2.15.1 Photon Details
  • 2.15.2 Photon Major Business
  • 2.15.3 Photon In Vivo Imaging Solutions Product and Solutions
  • 2.15.4 Photon In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.15.5 Photon Recent Developments and Future Plans
• 2.16 MILABS
  • 2.16.1 MILABS Details
  • 2.16.2 MILABS Major Business
  • 2.16.3 MILABS In Vivo Imaging Solutions Product and Solutions
  • 2.16.4 MILABS In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.16.5 MILABS Recent Developments and Future Plans
• 2.17 iThera Medical
  • 2.17.1 iThera Medical Details
  • 2.17.2 iThera Medical Major Business
  • 2.17.3 iThera Medical In Vivo Imaging Solutions Product and Solutions
  • 2.17.4 iThera Medical In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.17.5 iThera Medical Recent Developments and Future Plans
• 2.18 Aspect Imaging
  • 2.18.1 Aspect Imaging Details
  • 2.18.2 Aspect Imaging Major Business
  • 2.18.3 Aspect Imaging In Vivo Imaging Solutions Product and Solutions
  • 2.18.4 Aspect Imaging In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.18.5 Aspect Imaging Recent Developments and Future Plans
• 2.19 TOMOWAVE
  • 2.19.1 TOMOWAVE Details
  • 2.19.2 TOMOWAVE Major Business
  • 2.19.3 TOMOWAVE In Vivo Imaging Solutions Product and Solutions
  • 2.19.4 TOMOWAVE In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.19.5 TOMOWAVE Recent Developments and Future Plans
• 2.20 Trifoil Imaging
  • 2.20.1 Trifoil Imaging Details
  • 2.20.2 Trifoil Imaging Major Business
  • 2.20.3 Trifoil Imaging In Vivo Imaging Solutions Product and Solutions
  • 2.20.4 Trifoil Imaging In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.20.5 Trifoil Imaging Recent Developments and Future Plans
• 2.21 Clinx
  • 2.21.1 Clinx Details
  • 2.21.2 Clinx Major Business
  • 2.21.3 Clinx In Vivo Imaging Solutions Product and Solutions
  • 2.21.4 Clinx In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.21.5 Clinx Recent Developments and Future Plans
• 2.22 Raylight Technology
  • 2.22.1 Raylight Technology Details
  • 2.22.2 Raylight Technology Major Business
  • 2.22.3 Raylight Technology In Vivo Imaging Solutions Product and Solutions
  • 2.22.4 Raylight Technology In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.22.5 Raylight Technology Recent Developments and Future Plans
• 2.23 Beijing NOVEL MEDICAL Equipmen
  • 2.23.1 Beijing NOVEL MEDICAL Equipmen Details
  • 2.23.2 Beijing NOVEL MEDICAL Equipmen Major Business
  • 2.23.3 Beijing NOVEL MEDICAL Equipmen In Vivo Imaging Solutions Product and Solutions
  • 2.23.4 Beijing NOVEL MEDICAL Equipmen In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.23.5 Beijing NOVEL MEDICAL Equipmen Recent Developments and Future Plans
• 2.24 Tanon
  • 2.24.1 Tanon Details
  • 2.24.2 Tanon Major Business
  • 2.24.3 Tanon In Vivo Imaging Solutions Product and Solutions
  • 2.24.4 Tanon In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.24.5 Tanon Recent Developments and Future Plans
• 2.25 Guangzhou Biolight Biotechnology
  • 2.25.1 Guangzhou Biolight Biotechnology Details
  • 2.25.2 Guangzhou Biolight Biotechnology Major Business
  • 2.25.3 Guangzhou Biolight Biotechnology In Vivo Imaging Solutions Product and Solutions
  • 2.25.4 Guangzhou Biolight Biotechnology In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.25.5 Guangzhou Biolight Biotechnology Recent Developments and Future Plans
• 2.26 PINGSENG Healthcare
  • 2.26.1 PINGSENG Healthcare Details
  • 2.26.2 PINGSENG Healthcare Major Business
  • 2.26.3 PINGSENG Healthcare In Vivo Imaging Solutions Product and Solutions
  • 2.26.4 PINGSENG Healthcare In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.26.5 PINGSENG Healthcare Recent Developments and Future Plans
• 2.27 Fujifilm Visualsonics
  • 2.27.1 Fujifilm Visualsonics Details
  • 2.27.2 Fujifilm Visualsonics Major Business
  • 2.27.3 Fujifilm Visualsonics In Vivo Imaging Solutions Product and Solutions
  • 2.27.4 Fujifilm Visualsonics In Vivo Imaging Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.27.5 Fujifilm Visualsonics Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global In Vivo Imaging Solutions Revenue and Share by Players (2020-2025)
• 3.2 Market Share Analysis (2024)
  • 3.2.1 Market Share of In Vivo Imaging Solutions by Company Revenue
  • 3.2.2 Top 3 In Vivo Imaging Solutions Players Market Share in 2024
  • 3.2.3 Top 6 In Vivo Imaging Solutions Players Market Share in 2024
• 3.3 In Vivo Imaging Solutions Market: Overall Company Footprint Analysis
  • 3.3.1 In Vivo Imaging Solutions Market: Region Footprint
  • 3.3.2 In Vivo Imaging Solutions Market: Company Product Type Footprint
  • 3.3.3 In Vivo Imaging Solutions Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global In Vivo Imaging Solutions Consumption Value and Market Share by Type (2020-2025)
• 4.2 Global In Vivo Imaging Solutions Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

• 5.1 Global In Vivo Imaging Solutions Consumption Value Market Share by Application (2020-2025)
• 5.2 Global In Vivo Imaging Solutions Market Forecast by Application (2026-2031)

6 North America

• 6.1 North America In Vivo Imaging Solutions Consumption Value by Type (2020-2031)
• 6.2 North America In Vivo Imaging Solutions Market Size by Application (2020-2031)
• 6.3 North America In Vivo Imaging Solutions Market Size by Country
  • 6.3.1 North America In Vivo Imaging Solutions Consumption Value by Country (2020-2031)
  • 6.3.2 United States In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 6.3.3 Canada In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 6.3.4 Mexico In Vivo Imaging Solutions Market Size and Forecast (2020-2031)

7 Europe

• 7.1 Europe In Vivo Imaging Solutions Consumption Value by Type (2020-2031)
• 7.2 Europe In Vivo Imaging Solutions Consumption Value by Application (2020-2031)
• 7.3 Europe In Vivo Imaging Solutions Market Size by Country
  • 7.3.1 Europe In Vivo Imaging Solutions Consumption Value by Country (2020-2031)
  • 7.3.2 Germany In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 7.3.3 France In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 7.3.4 United Kingdom In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 7.3.5 Russia In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 7.3.6 Italy In Vivo Imaging Solutions Market Size and Forecast (2020-2031)

8 Asia-Pacific

• 8.1 Asia-Pacific In Vivo Imaging Solutions Consumption Value by Type (2020-2031)
• 8.2 Asia-Pacific In Vivo Imaging Solutions Consumption Value by Application (2020-2031)
• 8.3 Asia-Pacific In Vivo Imaging Solutions Market Size by Region
  • 8.3.1 Asia-Pacific In Vivo Imaging Solutions Consumption Value by Region (2020-2031)
  • 8.3.2 China In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 8.3.3 Japan In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 8.3.4 South Korea In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 8.3.5 India In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 8.3.6 Southeast Asia In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 8.3.7 Australia In Vivo Imaging Solutions Market Size and Forecast (2020-2031)

9 South America

• 9.1 South America In Vivo Imaging Solutions Consumption Value by Type (2020-2031)
• 9.2 South America In Vivo Imaging Solutions Consumption Value by Application (2020-2031)
• 9.3 South America In Vivo Imaging Solutions Market Size by Country
  • 9.3.1 South America In Vivo Imaging Solutions Consumption Value by Country (2020-2031)
  • 9.3.2 Brazil In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 9.3.3 Argentina In Vivo Imaging Solutions Market Size and Forecast (2020-2031)

10 Middle East & Africa

• 10.1 Middle East & Africa In Vivo Imaging Solutions Consumption Value by Type (2020-2031)
• 10.2 Middle East & Africa In Vivo Imaging Solutions Consumption Value by Application (2020-2031)
• 10.3 Middle East & Africa In Vivo Imaging Solutions Market Size by Country
  • 10.3.1 Middle East & Africa In Vivo Imaging Solutions Consumption Value by Country (2020-2031)
  • 10.3.2 Turkey In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 10.3.3 Saudi Arabia In Vivo Imaging Solutions Market Size and Forecast (2020-2031)
  • 10.3.4 UAE In Vivo Imaging Solutions Market Size and Forecast (2020-2031)

11 Market Dynamics

• 11.1 In Vivo Imaging Solutions Market Drivers
• 11.2 In Vivo Imaging Solutions Market Restraints
• 11.3 In Vivo Imaging Solutions Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 In Vivo Imaging Solutions Industry Chain
• 12.2 In Vivo Imaging Solutions Upstream Analysis
• 12.3 In Vivo Imaging Solutions Midstream Analysis
• 12.4 In Vivo Imaging Solutions Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source